On January 9th, 2023, PharmaBlock announced that it successfully obtained the Information Security Management System Certification (ISO/IEC 27001:2013).
As a global provider of innovative products and services throughout the pharmaceutical R&D process and commercial production. PharmaBlock has been placing a high priority on information security management. It has established and implemented strict procedures to protect clients' data and information, including but not limited to enhancing employee information security awareness, and upgrading hardware and software to prevent data leakage and loss.
"ISO/IEC 27001, as an internationally recognized information security management standard, provides systematic operational guidance, and certifies the compliance of our information security management system with the international standards. By achieving the ISO/IEC 27001 certification, PharmaBlock has shown our commitment with all the necessary controls in place to ensure that data security and confidentiality is maintained " said Ms. Yongmei Zeng, VP of Operation at PharmaBlock.
"Information Security is critical to our partners' success and to maintain their competitiveness. We have been very serious and had placed strict policy and procedures in protecting client’s information assets. As a trusted supplier, PharmaBlock will continue to strive for excellence in Quality, EHS, and IP Protection management to meet our partners compliance requirements and support their R&D programs to move forward smoothly." said Dr. Wenfang Miao, CEO of PharmaBlock.